Blood Stem Cell Mutations and Their Potential Role in Reducing Alzheimer's Disease Risk
Research reveals that mutations in blood stem cells, particularly in the TET2 gene, may significantly reduce the risk of late-onset Alzheimer's disease by enhancing brain immune responses.
A groundbreaking study published in Cell Stem Cell has uncovered intriguing links between mutations in blood stem cells and a decreased risk of developing late-onset Alzheimer's disease. Researchers from Baylor College of Medicine found that specific genetic mutations, particularly in the TET2 gene, may offer protective effects against the progression of this neurodegenerative disorder.
The investigation involved analyzing human data from the UK Biobank and conducting experiments on a mouse model. The team discovered that individuals with blood stem cells carrying mutations in TET2 had a 47% lower chance of developing Alzheimer's. Meanwhile, similar mutations in the DNMT3A gene did not confer such protective benefits.
In mouse models, transplantation of TET2-mutant bone marrow cells resulted in reduced cognitive decline and fewer beta-amyloid plaques, hallmark features of Alzheimer's disease. These results suggest that TET2-mutant immune cells, which can migrate into the brain, might aid in clearing amyloid deposits more effectively.
Lead researcher Dr. Katherine King explained that immune cells derived from TET2-mutant clones showed an increased ability to target brain damage related to Alzheimer's. This discovery challenges the traditional view that clonal hematopoiesis— the expansion of mutated blood cells— always promotes disease progression. Instead, certain mutations like those in TET2 may have protective roles.
The research emphasizes the importance of a mutation-specific perspective when evaluating clonal hematopoiesis and its health implications. Understanding how these mutations influence inflammation and immune response could lead to new strategies for preventing or treating Alzheimer's and other neurodegenerative diseases.
This study not only advances our knowledge of the complex relationship between blood cell genetics and brain health but also opens up new prospects for therapeutic interventions targeting immune cell function in Alzheimer's disease.
For more details, see the original research in Cell Stem Cell.
Source: https://medicalxpress.com/news/2025-07-blood-stem-cell-mutations-linked.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Genetic Adaptations Enable Turkana People to Survive in Extreme Desert Conditions
Scientists have discovered genetic adaptations in the Turkana people of Kenya that help them conserve water and survive in extreme desert conditions, revealing human resilience and evolution in harsh environments.
Group Prenatal Care Model Enhances Satisfaction, Support, and Trust Among Expectant Mothers
A Rutgers University study demonstrates that group prenatal care improves maternal satisfaction, trust, and support, contributing to better pregnancy outcomes and reduced disparities.
promising treatment for severe post-COVID syndrome in children using celiac disease drug
A groundbreaking study reveals that an experimental drug for celiac disease shows promise in treating severe post-COVID syndrome in children, offering new hope for MIS-C recovery.
Alcohol Consumption Linked to Increased Dementia Risk: New Research Finds No Safe Level
New large-scale research indicates that any level of alcohol consumption may increase the risk of dementia, with no evidence supporting protective effects of moderate drinking. Reducing alcohol intake is advised for brain health.